Navigation Links
Medelis Expands CRO Services to Medical Devices, Appoints Dr. Inder Makin as VP
Date:9/22/2009

Medelis, an oncology contract research organization in the US and Europe, is expanding its services to support medical devices under the guidance of Inder Makin, M.D., Ph.D., who joins the company as Vice President, Devices & Radiological Health. Medelis will support medical device manufacturers throughout the product life cycle including early design and prototyping, simulation, preclinical and phase I-III clinical studies. The company will also collaborate with clients to help them gain regulatory and marketing approvals.

Phoenix, AZ (PRWEB) September 22, 2009 -- Medelis, Inc., a full-service oncology contract research organization (CRO) in the US and Europe, today announced that the company is expanding its services to support medical devices under the guidance of Inder Makin, M.D., Ph.D., who joins the company as Vice President, Devices & Radiological Health.

Dr. Makin has more than 20 years of experience developing "concept to clinic" healthcare technologies in both academia and industry. He has developed medical ultrasound-based research programs at various institutes, taking concepts (including catheter-based devices for intravascular thrombolysis, transdermal drug delivery devices and non-invasive and intracorporeal tissue ablation devices) through feasibility and launch.

"We are extremely pleased to add Dr. Makin to our team of experts," said Medelis President & CEO Bob Bosserman. "His unique combination of medical and biomedical engineering expertise enables him to assist our clients in effectively developing and refining new device solutions for patients. He will also provide invaluable guidance in helping them obtain marketing approvals for successful commercialization."

Medelis will support medical device manufacturers throughout the product life cycle including early design and prototyping, simulation, preclinical and phase I-III clinical studies. The company will also collaborate with clients to help them gain regulatory and marketing approvals.

About Inder Makin, M.D., Ph.D.

During the past 20 years, Dr. Inder Makin has been active in strategy development and implementation of medical device technology from lab to market. He is a co-founder of Guided Therapy Systems, LLC (VP Applications and Clinical Development), Ulthera, Inc. and Xthetix, Inc. (VP Clinical and Application Development). Scientifically, he has been involved in the basic and applied research of ultrasound-tissue interaction, sound-bubble interaction and propagation of high-intensity ultrasound through tissue-like media. He has published more than 20 scientific papers, chaired various national and international conferences, and holds 8 patents. He received his M.D. from Jiwaji University, India in 1985, Diplom Ingenieur in Biomedical Engineering from Fachhochschule Hamburg, Germany, and his Ph.D. in Biomedical Engineering from Univ. of Texas at Austin, with specialization in nonlinear and medical acoustics. He is also an accredited medical sonographer (RDMS).

About Medelis

Medelis, Inc. is an oncology contract research organization providing a total solution for biotechnology and pharmaceutical companies seeking rapid drug development and approval. Medelis' medical founders, team physicians and clinical trial management physicians, including Dan Von Hoff, James Gourzis and Michael Gordon, are internationally-recognized oncology thought and opinion leaders who understand the future of personalized medicine and threshold of credibility trials. Medelis also supports medical device manufacturers from early design through regulatory approval.

Medelis is privately-held with US locations in Phoenix (headquarters), Nashville, Boston and Reno. The company's European CRO services are headquartered in Port Vendres, France.

# # #

Read the full story at http://www.prweb.com/releases/contractresearch/medicaldevices/prweb2902524.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medelis Expands CRO Services to Medical Devices, Appoints Dr. Inder Makin as VP
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... ... 23, 2016 , ... In a new case report published today in STEM ... who developed lymphedema after being treated for breast cancer benefitted from an injection of ... dealing with this debilitating, frequent side effect of cancer treatment. , Lymphedema ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):